Neuralink, under Elon Musk, plans to launch speech trials, aiming for healthy people to receive brain chip implants by 2030.

```

Elon Musk's brain-computer interface company Neuralink plans to launch a clinical trial in the United States in October, aiming to use its device to translate thoughts into text, bringing new communication possibilities to people with speech impairments.

On September 19, according to media reports, the U.S. Food and Drug Administration has approved Neuralink’s experimental device exemption, allowing it to begin testing devices that are not yet approved.

The company’s president, DJ Seo, said the new trial aims to read speech signals directly from the brain, enabling the capture of what people imagine themselves saying. He stated:

If you imagine saying something, we can capture it.

Currently, such companies only test their devices on patients with severe illnesses who are deemed to warrant the risks of brain surgery. Seo said:

The world we currently envision is one in which, in about 3 to 4 years, originally healthy people will have Neuralink devices implanted.

This technology is expected to enable humans to interact directly with large language model AI platforms at the speed of thought, even faster than normal speech, representing a significant milestone in the commercialization of brain-computer interface technology.

Expanding from Medical Applications to the Consumer Market

Neuralink is one of several companies developing brain-computer interface technology. Brain-computer interfaces allow direct communication between the brain and electronic devices, bypassing limbs or sensory organs.

Currently, the brain-computer interface industry primarily focuses on providing medical solutions for patients with severe illnesses.

The company and its competitors have been testing devices that help paralyzed patients control computers with their minds, and in some cases allow patients to type using virtual keyboards.

This technology is especially suitable for stroke patients or people with neurodegenerative diseases such as ALS. ALS damages the neurons that control movement; patients have normal thinking ability but cannot control the muscles to produce speech. Neural implants can transmit patients’ speech signals directly to a computer.

Neuralink’s short-term goal is to improve patients’ quality of life, while its long-term goal is to fully enhance human capabilities.

Seo clearly indicated at an event at the Korea Advanced Institute of Science and Technology in Seoul earlier this week that the company hopes to implant devices in healthy humans before 2030, moving toward the ultimate goal of creating consumer-grade technology.

DJ Seo envisions that in the future, users will be able to communicate directly with large language models (LLMs) and other AI platforms through their thoughts, bypassing keyboards. He said:

We think it is entirely possible to converse with the latest AI models at the speed of thought—even faster than you can speak.

Other scientists have already shown in published research that they can directly read intended and even imagined speech from the human brain.

Neuralink's plan to expand to healthy individuals represents an important turning point for the industry, but analysts believe there will be more stringent safety evaluations and regulatory scrutiny in the future.

Risk Warning and DisclaimerThe market has risks, and investments need to be made cautiously. This article does not constitute personal investment advice, nor does it take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their particular circumstances. You are solely responsible for any investment made based on this information. ```